MedTherapy Biotechnology

Cell, Gene & Immunotherapies for Cancer

MTB-002 Clin0 DLBCL; MTB-003 Clin0 multiple myeloma; MTB-004 RD hematologic malignancies; MTB-005 RD solid tumors

MedTherapy Biotechnology is manufacturing cell, gene and immunological therapies for the treatment of cancer. The manufacturing of CAR-T cell gene therapies for cancer encompasses three components: clinical trials, manufacturing of the therapy and manufacturing the most critical raw materials called virus vectors. MedTherapy has all of these activities developed in-house, facilitating the production of affordable and accessible therapies. MedTherapy offers end-to-end services for its partners and helps bring products from early stage to commercialisation and beyond.